Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alprostadil in COVID-19
NCT04536363Phase 2Withdrawn
- Start
- Dec 2020
- Primary completion
- Dec 2020
01
Overview
A Phase 2 trial of Alprostadil Liposomes for Injection in coronavirus disease 2019 (COVID-19). Planned start Dec 2020; status: withdrawn.
02
Drugs
Alprostadil Liposomes for Injection
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04536363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04536363.